Saint Bernard Pharmaceuticals - B (02257.HK) establishes an external scientific advisory board.

Zhongtong Financial APP News, Sanofi-B (02257.HK) announced that on July 21, 2026, the company established an External Scientific Advisory Committee (Scientific Advisory Board) to provide independent and authoritative scientific guidance for the research and development projects of the group's treatment pipeline. The Scientific Advisory Board is composed of five internationally renowned interdisciplinary experts with deep expertise in RNA delivery technology, RNAi drug discovery, oncology research and development (R&D), clinical translational medicine, chemistry, manufacturing and control (CMC) activities, and global drug regulatory compliance.